Search clinical trials for: Enoxaparin sodium 20 mg (=2000IU)

Total 1816 results

Biocad

Completed

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Deep Vein Thrombosis

Russian Federation
Daiichi Sankyo Co., Ltd.

Completed

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Embolism and Thrombosis | Thrombosis | Deep Vein Thrombosis | Thromboembolism | Venous Thromboembolism | Arthroplasty, Replacement, Hip

Japan, Taiwan
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Pregnancy | Heart; Complications, Valve, Prosthesis

Turkey
Oregon Health and Science University

Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Trauma | Surgery | Deep Vein Thrombosis (DVT) | Thromboembolic Events

United States
French Cardiology Society

Completed

Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

Renal Failure | Acute Coronary Syndrome

France
University of Cincinnati
United States Air Force

Completed

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

Venous Thromboembolism | Traumatic Injury

United States
Sarah Sabry Hashem

Completed

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

Mitral Valve Disease

Egypt
Oregon Health and Science University
National Trauma Research Institute; Medical Research Foundation, Oregon

Completed

Thrombelastography Based Dosing of Enoxaparin

Thromboembolic Complications

United States
Loyola University

Withdrawn

Timing of VTE Prophylaxis in TBI

TBI (Traumatic Brain Injury) | VTE (Venous Thromboembolism)

United States
Assistance Publique - Hôpitaux de Paris

Suspended

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients (Childbenox)

Cirrhosis

France
Mansoura University

Unknown

Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study

Morbid Obesity | Pulmonary Embolism

Egypt
Mashhad University of Medical Sciences

Unknown

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Esophageal Neoplasms

Iran, Islamic Republic of
Chemi S.p.A.

Completed

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

Enoxaparin Sodium is Administered to Healthy Volunteers

United Kingdom
Pirogov Russian National Research Medical University

Recruiting

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. (IDAHeT)

Venous Thromboembolism

Russian Federation
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Venous Thromboembolism

Brazil
Indonesia University
PT Metiska Farma

Completed

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Enoxaparin

Indonesia
King Abdullah International Medical Research Center

Completed

Efficacy and Safety for Different Regimen of VTE Pharmacoprophylaxis Among Severely Burn Patients

Burns

Saudi Arabia
V.K.V. American Hospital, Istanbul

Completed

Low Molecular Weight Heparin in Recurrent Implantation Failure

Infertility | Recurrent Implantation Failure | Fertilization in Vitro

Turkey
PT Bio Farma

Recruiting

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Safety Issues | Effect of Drug

Indonesia
University Hospital, Brest

Terminated

Prevention of Unexplained Recurrent Abortion by Enoxaparine (PREFIX)

Alive and Viable Births

France
Venus Remedies Limited

Completed

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Healthy

India
Sanofi

Completed

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Venous Thromboembolism

France, Russian Federation, Spain, Italy, Argentina, Belgium, Brazil, Canada, Colombia, Germany, Israel, Mexico, Poland, United States, Australia, Austria, India, South Africa, United Kingdom, Tunisia
Eisai Co., Ltd.

Completed

A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)

Healthy

Japan
Sanofi

Completed

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

Myocardial Infarction | Acute ST-Segment Elevation

Canada, Brazil, Poland, Romania, Russian Federation, Ukraine, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Estonia, India, Malaysia, Singapore, Slovakia, Belgium, Mexico, Uruguay, Argentina, Croatia, Austr... and more
Rovi Pharmaceuticals Laboratories
PRA Health Sciences

Completed

Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

Healthy
GlycoMimetics Incorporated
University of Michigan

Completed

Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Healthy Volunteers

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Unknown

Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients (INHIXACOV19)

COVID-19

Italy
Tel-Aviv Sourasky Medical Center

Unknown

Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity

Obesity

Israel
University of Oulu
University of Helsinki

Unknown

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Intracerebral Hemorrhage

Finland
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Radial Artery Occlusion

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Recruiting

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty

China
GlycoMimetics Incorporated
University of Michigan

Terminated

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Deep Venous Thrombosis

United States
Portola Pharmaceuticals

Completed

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa

Bleeding

United States
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
University of Utah
University of Michigan

Completed

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Surgery | Venous Thromboembolism | Deep Venous Thrombosis

United States
Vanda Pharmaceuticals

Completed

Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)

Non-24-Hour-Sleep-Wake Disorder
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis

Gastrointestinal Diseases | Gastroesophageal Reflux | Esophageal Motility Disorders | Deglutition Disorders | Esophageal Diseases | Esophagitis | Reflux Esophagitis

China
Sanofi

Completed

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery (TREK)

Venous Thromboembolism

Poland, Romania, Russian Federation, Portugal, Sweden, Turkey, Bulgaria, Malaysia, Philippines, Taiwan, Mexico, Argentina, Denmark, Finland, Norway, Colombia, Chile, Thailand, Greece
Wake Forest University Health Sciences

Terminated

Clot Dissolving Treatment for Blood Clots in the Lungs

Pulmonary Embolism

United States
Oregon Health and Science University

Terminated

Below Knee DVT Study

Deep Vein Thrombosis (DVT) | Blood Clots

United States
Bristol-Myers Squibb

Completed

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Venous Thrombosis | Pulmonary Embolism

United States, Argentina, Canada, Mexico, Puerto Rico, Israel, Australia, Poland, Denmark
Bayer

Completed

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Venous Thromboembolism

United States, Canada
Lebanese American University

Completed

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Renal Impairment | Venous Thromboembolism

Lebanon
University of Utah

Completed

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
Peking Union Medical College Hospital

Completed

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) (OPTIENOX-PCI)

Coronary Artery Disease | Percutaneous Coronary Intervention

China
Hannover Medical School

Terminated

Taxotere-Enoxaparin-(ENOXA)-Study

Non-small Cell Lung Cancer

Germany
Eisai Co., Ltd.

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects

Japan
Assistance Publique - Hôpitaux de Paris

Recruiting

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) (OPTI-TREX)

Pediatric Kidney Transplant Recipients

France
Bayer

Completed

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects

Pharmacokinetics

Germany
Mylan Pharmaceuticals Inc

Completed

Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg

Healthy

United States

Search clinical trials for: Enoxaparin sodium 20 mg (=2000IU)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations